Evidence map›Paper›PMID 32349719›Full record

ArticleBMC pulmonary medicine2020

Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation.

Benjamin Coiffard, Eloi Prud'Homme, Sami Hraiech, Nadim Cassir, Jérôme Le Pavec, Romain Kessler, Federica Meloni, Marc Leone, Pascal Alexandre Thomas, Martine Reynaud-Gaubert and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC pulmonary medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  7. RefractoryInfection and drug resistance · 2023
    Article
  8. Perioperative antibiotic stewardship in the organ transplant setting.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Review
  9. Outpatient and peri-operative antibiotic stewardship in solid organ transplantation.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Review
  10. Medical Complications of Lung Transplantation.Journal of chest surgery · 2022
    Article
  11. Article
  12. Article
  13. Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  14. Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  15. Management of lung transplantation in the COVID-19 era-An international survey.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  16. Infections Management in the Lung Transplant Setting in Italy: A Web-Survey.Transplant infectious disease : an official journal of the Transplantation Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Benjamin CoiffardDepartment of Respiratory Medicine and Lung Transplantation, Aix Marseille University, APHM, Hôpital Nord, 13015, Marseille, France. bcoiffard.aphm@gmail.com.ORCID http://orcid.org/0000-0002-8896-5346
Eloi Prud'HommeAix Marseille University, APHM, Hôpital Nord, Intensive Care Unit, Marseille, France.
Sami HraiechAix Marseille University, APHM, Hôpital Nord, Intensive Care Unit, Marseille, France.
Nadim CassirAix Marseille University, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Jérôme Le PavecDepartment of Cardio-Thoracic Surgery and Heart-Lung Transplantation, Hôpital Marie-Lannelongue, Le Plessis-Robinson, France.
Romain KesslerDepartment of Respiratory Medicine and Lung Transplantation, Federation of Translational Medicine of Strasbourg (FMTS), Nouvel Hôpital Civil, Strasbourg, France.
Federica MeloniDepartment of Medical Sciences and Infective Diseases, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
Marc LeoneAix Marseille University, APHM, Hôpital Nord, Department of Thoracic Surgery, Marseille, France.
Pascal Alexandre ThomasAix Marseille University, APHM, Hôpital Nord, Department of Anesthesiology, Marseille, France.
Martine Reynaud-GaubertDepartment of Respiratory Medicine and Lung Transplantation, Aix Marseille University, APHM, Hôpital Nord, 13015, Marseille, France.
Laurent PapazianAix Marseille University, APHM, Hôpital Nord, Intensive Care Unit, Marseille, France.
Aix-Marseille Université · FRHôpital Civil, Strasbourg · FRHôpital Marie Lannelongue · FRIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfection is the most common cause of mortality within the first year after lung transplantation (LTx). The management of perioperative antibiotic therapy is a major issue, but little is known about worldwide practices.

methodsWe sent by email a survey dealing with 5 daily clinical vignettes concerning perioperative antibiotic therapy to 180 LTx centers around the world. The invitation and a weekly reminder were sent to lung transplant specialists for a single consensus answer per center during a 3-month period.

resultsWe received a total of 99 responses from 24 countries, mostly from Western Europe (n = 46) and the USA (n = 34). Systematic screening for bronchial recipient colonization before LTx was mostly performed with sputum samples (72%), regardless of the underlying lung disease. In recipients without colonization, antibiotics with activity against gram-negative bacteria resistant strains (piperacillin / tazobactam, cefepime, ceftazidime, carbapenems) were reported in 72% of the centers, and antibiotics with activity against methicillin-resistant Staphylococcus aureus (mainly vancomycin) were reported in 38% of the centers. For these recipients, the duration of antibiotics reported was 7 days (33%) or less (26%) or stopped when cultures of donor and recipients were reported negatives (12%). In recipients with previous colonization, antibiotics were adapted to the susceptibility of the most resistant strain and given for at least 14 days (67%).

conclusionPractices vary widely around the world, but resistant bacterial strains are mostly targeted even if no colonization occurs. The antibiotic duration reported was longer for colonized recipients.

Indexed as

Lung TransplantationPerioperative MedicineAnti-Bacterial AgentsAntibiotic ProphylaxisEuropeGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansImmunocompromised HostSputumUnited StatesAnti-Bacterial AgentsAntibiotic therapyBronchial colonizationLung transplantationPerioperativeSurvey

Identifiers

PMID32349719
PMCPMC7191774
OpenAlexW3023780886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.